109 related articles for article (PubMed ID: 6431792)
1. Effects of dilazep on coronary and systemic hemodynamics in humans.
Marzilli M; Simonetti I; Levantesi D; Trivella MG; De Nes M; Perissinotto A; Puntoni R; Buzzigoli G; Boni C; Michelassi C
Am Heart J; 1984 Aug; 108(2):276-85. PubMed ID: 6431792
[TBL] [Abstract][Full Text] [Related]
2. Effect of dilazep on coronary and systemic circulations.
Marzilli M; Trivella MG; Levantesi D; Pelosi G; Dalle Vacche M; Taddei L; L'Abbate A
Pharmacology; 1985; 31(2):82-7. PubMed ID: 4023048
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of a single high dose of dilazep by oral route.
Ibba GV; Terrosu P; Franceschino V; Contini GM
Int J Cardiol; 1986 Jun; 11(3):337-48. PubMed ID: 3721632
[TBL] [Abstract][Full Text] [Related]
4. [The pharmacology of the combination drug dilazep/beta-acetyldigoxin].
Zechel VH; Brock N
Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1905-14. PubMed ID: 4480353
[No Abstract] [Full Text] [Related]
5. [Animal experiment study on the coronary and circulatory effect of dipyridamole, carbocromen, hexobendine, dilazep and glucagon].
Reploh HD
Arzneimittelforschung; 1973 May; 23(5):629-39. PubMed ID: 4740201
[No Abstract] [Full Text] [Related]
6. Systemic and coronary hemodynamic effects of diazepam in patients with normal and diseased coronary arteries.
Côté P; Guéret P; Bourassa MG
Circulation; 1974 Dec; 50(6):1210-6. PubMed ID: 4430116
[No Abstract] [Full Text] [Related]
7. The effect of dilazep on blood flow and oxygen handling in the early stages of canine myocardial infarction. Simultaneous comparison with changes in the normal myocardium.
Marshall RJ; Parratt JR
Naunyn Schmiedebergs Arch Pharmacol; 1974; 281(4):427-36. PubMed ID: 4275262
[No Abstract] [Full Text] [Related]
8. The effects of lidocaine on systemic and coronary hemodynamics.
Thomsen JH; Terry W; Stenlund RR; Querimit S; Rowe GG
Arch Int Pharmacodyn Ther; 1971 Nov; 194(1):83-92. PubMed ID: 5123869
[No Abstract] [Full Text] [Related]
9. [Effects of dilazep on cardiac function, coronary circulation and myocardial energy metabolism].
Katano Y; Takeda K; Otorii T; Horii D; Imai S
Nihon Yakurigaku Zasshi; 1974 Mar; 70(2):305-14. PubMed ID: 4858949
[No Abstract] [Full Text] [Related]
10. Coronary and systemic haemodynamic effects of prostaglandins in the unanaesthetized dog.
Bloor CM; White FC; Sobel BE
Cardiovasc Res; 1973 Mar; 7(2):156-66. PubMed ID: 4694100
[No Abstract] [Full Text] [Related]
11. Effect of endotoxin on myocardial performance.
Hinshaw LB; Archer LT; Greenfield LJ; Miller JA; Guenter CA
J Trauma; 1972 Dec; 12(12):1056-62. PubMed ID: 4568504
[No Abstract] [Full Text] [Related]
12. Systemic and coronary hemodynamic effects of sodium nitroprusside.
Rowe GG; Henderson RH
Am Heart J; 1974 Jan; 87(1):83-7. PubMed ID: 4808762
[No Abstract] [Full Text] [Related]
13. Effects of magnesium chloride on cardiovascular hemodynamics in the neurally intact dog.
Friedman HS; Nguyen TN; Mokraoui AM; Barbour RL; Murakawa T; Altura BM
J Pharmacol Exp Ther; 1987 Oct; 243(1):126-30. PubMed ID: 3668845
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.
Gray R; Chatterjee K; Vyden JK; Ganz W; Forrester JS; Swan HJ
Am Heart J; 1975 Sep; 90(3):346-52. PubMed ID: 1163426
[TBL] [Abstract][Full Text] [Related]
15. [Effects of glucagon on systemic circulation, coronary blood flow and myocardial oxygen consumption in the anesthetized dog (author's transl)].
Tarnow J; Gethmann JW; Patschke D; Weymar A; Eberlein HJ
Arzneimittelforschung; 1975; 25(12):1906-10. PubMed ID: 1243661
[TBL] [Abstract][Full Text] [Related]
16. The effects of a new coronary vasocilator (BAY-a-1040, Nifedipine) on the coronary and systemic haemodynamics in the anaesthetized dog.
Maxwell GM; Rencis V
Aust J Exp Biol Med Sci; 1973 Feb; 51(1):117-20. PubMed ID: 4699546
[No Abstract] [Full Text] [Related]
17. Effects of intravenous nesiritide on human coronary vasomotor regulation and myocardial oxygen uptake.
Michaels AD; Klein A; Madden JA; Chatterjee K
Circulation; 2003 Jun; 107(21):2697-701. PubMed ID: 12742984
[TBL] [Abstract][Full Text] [Related]
18. Effects of dilazep on regional myocardial blood flow during selective coronary hypotension.
Fujii M; Kikuchi Y; Koyanagi S; Okamatsu S; Tomoike H; Nakamura M
Arzneimittelforschung; 1981; 31(12):2067-71. PubMed ID: 7199300
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of myocardial reactive hyperemia and adenosine-induced coronary vasodilation by dilazep, a new adenosine potentiator.
Saito D; Kusachi S; Nagashima H; Haraoka S
Arzneimittelforschung; 1982; 32(9):1029-32. PubMed ID: 6890820
[TBL] [Abstract][Full Text] [Related]
20. Intravenous carbochromen: a potent and effective drug for estimation of coronary dilatory capacity.
Opherk D; Schuler G; Waas W; Dietz R; Kübler W
Eur Heart J; 1990 Apr; 11(4):342-7. PubMed ID: 2185023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
